This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
In Washington, governors from both parties pressed for a sweeping review of the nation’s workforce policy amid AI-dri...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
War-time disruption in the Middle East drives oil higher and pushes up consumer costs, threatening to accelerate infl...
Bitcoin price confirms recovery as traders digest geopolitical tensions, supply dynamics, and policy expectations. Th...
Bitcoin has pulled back sharply, but March could offer a disciplined entry for thoughtful investors. Here are three s...
BlackRock CEO Larry Fink warns that AI disruption could raise unemployment among new graduates, even in a steady econ...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
Palo Alto Networks has accelerated into platform play by acquiring three firms over the past year. This article break...
Webull (Bull) 2025 earnings offer a window into user growth, revenue mix, and paths to profitability. This guide brea...